4//SEC Filing
Long Daniel D. 4
Accession 0001193125-25-280756
CIK 0001984086other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:13 PM ET
Size
5.1 KB
Accession
0001193125-25-280756
Insider Transaction Report
Form 4
Septerna, Inc.SEPN
Long Daniel D.
SVP, Drug Discovery
Transactions
- Sale
Common Stock
2025-11-10$18.06/sh−3,501$63,223→ 92,911 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.04 to $18.16. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes 3,501 shares acquired under the Septerna, Inc. 2024 Employee Stock Purchase Plan on October 31, 2025 in transactions that were exempt under Rule 16b-3(c).
Documents
Issuer
Septerna, Inc.
CIK 0001984086
Entity typeother
Related Parties
1- filerCIK 0002040349
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:13 PM ET
- Size
- 5.1 KB